8.20K
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Medical - Specialties
Industry

ChromoCure, Inc. develops and provides proprietary cancer detection systems. The company offers Chromosomal Scanner Series 200, a cancer detection system to measure the genomic characteristic found in 100% of all cancers and never found in normal cells. It also applies its science and technology to non-toxic and non-invasive approaches to cancer therapy and cure research.

Similar securities

Based on sector and market capitalization

Report issue